Vanderbilt Health researchers plan to build an artificial intelligence agent inside their electronic health record system to reduce how long patients with Alzheimer's disease wait before receiving their first infusion of anti-amyloid therapy.
The 18-month, $600,000 project targets the referral from primary care or geriatrics to neurology, the stage where the team believes avoidable delay accumulates. The grant comes from Eli Lilly and Company.
